<?xml version="1.0" encoding="UTF-8"?>
<p id="p0390">Fungal infections are associated with high morbidity and mortality rates. These infections are a global public health problem, mainly in immunocompromised patients. The treatment options are limited due to a few number of therapeutic classes available (
 <xref rid="bib121" ref-type="bibr">Hadrich and Ayadi, 2018</xref>) in addition to the increase of resistance cases. Therefore, new therapeutic options are highly needed.
</p>
